0001127602-18-033265.txt : 20181115 0001127602-18-033265.hdr.sgml : 20181115 20181115204507 ACCESSION NUMBER: 0001127602-18-033265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181114 FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossi Federico CENTRAL INDEX KEY: 0001720634 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 181188496 MAIL ADDRESS: STREET 1: C/O APELLIS PHARMACEUTICALS, INC. STREET 2: 6400 WESTWIND WAY, SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 BUSINESS PHONE: 502-241-4114 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-11-14 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001720634 Grossi Federico C/O APELLIS PHARMACEUTICALS, INC 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014 1 See Remarks Common Stock 2018-11-14 4 M 0 6250 3.20 A 22456 D Stock Option (Right to Buy) 3.20 2018-11-14 4 M 0 6250 0 D 2024-12-11 Common Stock 6250 55573 D This option was granted on December 12, 2014 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service. /s/ David Watson, attorney-in-fact for Dr. Federico Grossi 2018-11-15